Impact of body mass index, age and varicocele on reproductive hormone profile from elderly men

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Citação
INTERNATIONAL BRAZ J UROL, v.42, n.2, p.365-372, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To study the impact of obesity, age and varicocele on sexual hormones fof adult and elderly men. Materials and Methods: 875 men who were screened for prostate cancer were enrolled in this study. Data recorded comprised age, body mass index (BMI), serum levels of total testosterone (TT), free testosterone (FT), sex hormone-binding globulin (SHBG), luteinizing hormone (LH) and follicular stimulating hormone (FSH). Patients were divided in groups according to their BMI in underweight, normal weight, overweight and obese grades 1, 2 or 3. First, it was studied the association between age, BMI, and hormone profile. Then, clinical varicocele was evaluated in 298 patients to assess its correlation to the others parameters. Results: Obese patients had lower levels of TT, FT and SHBG (p<0.001) compared to underweight or normal weight patients. There were no differences in age (p=0.113), FSH serum levels (p=0.863) and LH serum levels (p=0.218) between obese and non-obese patients. Obese grade 3 had lower levels of TT and FT compared to obese grade 1 and 2 (p<0.05). There was no difference in the SHBG levels (p=0.120) among obese patients. There was no association between varicocele and BMI; and varicocele did not impact on testosterone or SHBG levels. Conclusions: Men with higher BMI have a lower serum level of TT, FT and SHBG. The presence of clinical varicocele as well as its grade has no impact on hormone profile in elderly men.
Palavras-chave
Aging, Receptors, FSH, Receptors, LH, Obesity, Gonadal Steroid Hormones, Varicocele
Referências
  1. Abdel-Meguid TA, 2014, UROLOGY, V84, P1081, DOI 10.1016/j.urology.2014.05.029
  2. Soylemez H, 2012, INT BRAZ J UROL, V38, P116, DOI 10.1590/S1677-55382012000100016
  3. Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x
  4. Fretz PC, 2002, UROL CLIN N AM, V29, P921, DOI 10.1016/S0094-0143(02)00075-7
  5. Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
  6. Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026
  7. Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724
  8. SU LM, 1995, J UROLOGY, V154, P1752, DOI 10.1016/S0022-5347(01)66776-4
  9. Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
  10. GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997
  11. Zhang XW, 2012, CHINESE MED J-PEKING, V125, P3806, DOI 10.3760/cma.j.issn.0366-6999.2012.21.011
  12. ANDO S, 1984, J ANDROL, V5, P163
  13. GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016
  14. Tan RS, 2002, INT J ANDROL, V25, P195, DOI 10.1046/j.1365-2605.2002.00356.x
  15. Meeker JD, 2007, J ANDROL, V28, P397, DOI 10.2164/jandrol.106.001545
  16. Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054
  17. Schlegel PN, 2011, FERTIL STERIL, V96, P1288, DOI 10.1016/j.fertnstert.2011.10.033
  18. DUBIN L, 1970, FERTIL STERIL, V21, P606
  19. Surampudi PN, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/625434
  20. Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101
  21. MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047
  22. Redmon JB, 2002, HUM REPROD UPDATE, V8, P53, DOI 10.1093/humupd/8.1.53
  23. Tanrikut C, 2011, BJU INT, V108, P1480, DOI 10.1111/j.1464-410X.2010.10030.x
  24. Luo DY, 2011, ASIAN J ANDROL, V13, P287, DOI 10.1038/aja.2010.111
  25. Li FP, 2012, INT J UROL, V19, P149, DOI 10.1111/j.1442-2042.2011.02890.x
  26. Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830
  27. Chanc WR, 2012, J UROLOGY, V187, P599
  28. Della Morte Ennio, 2002, Arch Ital Urol Androl, V74, P152
  29. Ogden CL, 2013, NCHS DATA BRIEF, V131, P1
  30. Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb
  31. Prader A, 1966, Triangle, V7, P240
  32. Sathya Srini V, 2011, INT J ENDOCRINOL, V2011
  33. Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33
  34. von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455